The role of testosterone in SARS-CoV-2 infection

Dr Marta Camici investigates the link between low testosterone levels and the severity of COVID-19 cases in patients

Data from multiple countries has shown gender imbalances in COVID-19 severity and risk of mortality, with worse outcomes seen in men. To explore why male gender is a major risk factor for more severe disease, Marta Camici, of The Lazzaro Spallanzani National Institute for Infectious Diseases (IRCCS), has explored the links between testosterone and COVID-19. Her research findings suggest that […]

Read More… from The role of testosterone in SARS-CoV-2 infection

AMP-activated kinase as a therapeutic target in prostate cancer

Prostate cancer is one of the leading causes of mortality among men worldwide.

Pharmacological treatment of prostate cancer has advanced significantly in recent years. However, while the newest therapies are initially effective in reducing tumour size, most patients eventually develop drug resistance and the recurrence of malignant spread. Professor Inés Díaz-Laviada and her team at the Alcala University in Madrid, Spain, have demonstrated that long-term treatments may induce the transformation of cancer cells […]

Read More… from AMP-activated kinase as a therapeutic target in prostate cancer

Treating low testosterone in males: A nasal gel shows promising results

Natesto increases testosterone into normal range.

Ranjith Ramasamy is an Associate Professor in the Department of Urology, University of Miami. His clinical work focuses on treating male infertility and sexual dysfunction, and he is involved in several research projects. One such project investigated a novel treatment for low testosterone, a nasal gel known as Natesto. An initial clinical trial showed that Natesto is a promising treatment […]

Read More… from Treating low testosterone in males: A nasal gel shows promising results